Protective Effect of Dietary Tocotrienols against Infection and Inflammation‐induced Hyperlipidemia: AnIn VivoandIn SilicoStudy
- 11 March 2011
- journal article
- research article
- Published by Wiley in Phytotherapy Research
- Vol. 25 (11) , 1586-1595
Abstract
Currently used hypolipidemic drugs, Fluvastatin and Atorvastatin, act via inhibiting the rate‐limiting enzyme 3‐hydroxy‐3‐methyl‐glutaryl‐coenzyme A (HMG‐CoA) reductase of the mevalonate pathway. The associated severe side‐effects of these statins led us to explore the therapeutic potentials of naturally occurring Tocomin (mixture of dietary α‐, β‐, γ‐ and δ‐tocotrienols). Tocomin (10 mg) was orally administered daily for 10 days before and 12 h after bacterial lipopolysaccharide (200 μg) or 24 h after zymosan (20 mg) or turpentine (0.5 mL) to Syrian hamsters. The data showed that Tocomin significantly reduced the levels of plasma and lipoprotein lipids, cholesterol, apoB, small dense (sd)‐LDL as well as LDL in the hyperlipidemia‐induced hamsters. Further, the mechanism of action of α‐, β‐, γ‐ and δ‐tocotrienols was validated by docking studies with HMG‐CoA reductase enzyme using the Molegro Virtual Docker. The inhibition of HMG‐CoA reductase predicted in terms of MolDockScore and interaction energy suggest the comparative potential in the descending order: Atorvastatin > Fluvastatin ~ δ > γ > β > α. The results favor the daily intake of naturally occurring tocotrienols as dietary supplement in the prevention and treatment of infection/inflammation induced dyslipidemia compared with the hypolipidemic drugs. Copyright © 2011 John Wiley & Sons, Ltd.Keywords
Funding Information
- University Grant Commission (UGC), New Delhi
This publication has 46 references indexed in Scilit:
- Small dense LDL and VLDL predict common carotid artery IMT and elicit an inflammatory response in peripheral blood mononuclear and endothelial cellsAtherosclerosis, 2009
- PubChem: a public information system for analyzing bioactivities of small moleculesNucleic Acids Research, 2009
- Significance of small dense low-density lipoprotein-cholesterol concentrations in relation to the severity of coronary heart diseasesAtherosclerosis, 2006
- MolDock: A New Technique for High-Accuracy Molecular DockingJournal of Medicinal Chemistry, 2006
- Dyslipidemia and inflammation: an evolutionary conserved mechanismClinical Nutrition, 2005
- Molecular docking of the highly hypolipidemic agent α-asarone with the catalytic portion of HMG-CoA reductaseBioorganic & Medicinal Chemistry Letters, 2005
- Progression of Atherosclerosis as Assessed by Carotid Intima-Media Thickness in Patients With HIV InfectionCirculation, 2004
- Dental infections and coronary atherosclerosisAtherosclerosis, 1993
- Relation of the level of high-density lipoprotein subfractions to the presence and extent of coronary artery diseaseThe American Journal of Cardiology, 1992
- Interaction of dietary cholesterol and triglycerides in the regulation of hepatic low density lipoprotein transport in the hamster.Journal of Clinical Investigation, 1988